The global market for Coccidia Virus Live Vaccine was valued at US$ 95 million in the year 2024 and is projected to reach a revised size of US$ 136 million by 2031, growing at a CAGR of 5.1% during the forecast period.

Coccidia Virus Live Vaccine Market

The coccidia virus live vaccine is a vaccine used to prevent coccidiosis in poultry, such as chickens. Coccidiosis, caused by Eimeria spp., is a parasitic infection that primarily affects the intestines of poultry, leading to diarrhea, weight loss, and even death. This vaccine uses attenuated live coccidia viruses to simulate an infection, stimulating the immune system to produce antibodies and enhancing the poultry's immunity against future coccidia infections. Compared to traditional coccidiostat treatments, the vaccine not only helps reduce the development of drug resistance but also improves poultry production performance, such as weight gain in broilers and egg production in layers, promoting a more sustainable and environmentally friendly poultry industry.

North American market for Coccidia Virus Live Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Coccidia Virus Live Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Coccidia Virus Live Vaccine include MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, Nisseiken, Biopharm, Ceva Santé Animale, Vaxxinova, Foshan Standard Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coccidia Virus Live Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coccidia Virus Live Vaccine.

The Coccidia Virus Live Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Coccidia Virus Live Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Coccidia Virus Live Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Coccidia Virus Live Vaccine Market Report

Report Metric	Details
Report Name	Coccidia Virus Live Vaccine Market
Accounted market size in year	US$ 95 million
Forecasted market size in 2031	US$ 136 million
CAGR	5.1%
Base Year	year
Forecasted years	2025 - 2031
by Type	Bivalent Vaccine Trivalent Vaccine Quadrivalent Vaccine
by Application	Poultry Rabbit Other
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, Nisseiken, Biopharm, Ceva Santé Animale, Vaxxinova, Foshan Standard Biotech, Qilu Qingda Bio-Pharmaceutical, Skystar Bio-pharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coccidia Virus Live Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Coccidia Virus Live Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Coccidia Virus Live Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Coccidia Virus Live Vaccine Market growing?

Ans: The Coccidia Virus Live Vaccine Market witnessing a CAGR of 5.1% during the forecast period 2025-2031.

What is the Coccidia Virus Live Vaccine Market size in 2031?

Ans: The Coccidia Virus Live Vaccine Market size in 2031 will be US$ 136 million.

Who are the main players in the Coccidia Virus Live Vaccine Market report?

Ans: The main players in the Coccidia Virus Live Vaccine Market are MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, Nisseiken, Biopharm, Ceva Santé Animale, Vaxxinova, Foshan Standard Biotech, Qilu Qingda Bio-Pharmaceutical, Skystar Bio-pharm

What are the Application segmentation covered in the Coccidia Virus Live Vaccine Market report?

Ans: The Applications covered in the Coccidia Virus Live Vaccine Market report are Poultry, Rabbit, Other

What are the Type segmentation covered in the Coccidia Virus Live Vaccine Market report?

Ans: The Types covered in the Coccidia Virus Live Vaccine Market report are Bivalent Vaccine, Trivalent Vaccine, Quadrivalent Vaccine

1 Coccidia Virus Live Vaccine Market Overview

1.1 Product Definition

1.2 Coccidia Virus Live Vaccine by Type

1.2.1 Global Coccidia Virus Live Vaccine Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Bivalent Vaccine

1.2.3 Trivalent Vaccine

1.2.4 Quadrivalent Vaccine

1.3 Coccidia Virus Live Vaccine by Application

1.3.1 Global Coccidia Virus Live Vaccine Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Poultry

1.3.3 Rabbit

1.3.4 Other

1.4 Global Market Growth Prospects

1.4.1 Global Coccidia Virus Live Vaccine Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Coccidia Virus Live Vaccine Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Coccidia Virus Live Vaccine Production Estimates and Forecasts (2020-2031)

1.4.4 Global Coccidia Virus Live Vaccine Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Coccidia Virus Live Vaccine Production Market Share by Manufacturers (2020-2025)

2.2 Global Coccidia Virus Live Vaccine Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Coccidia Virus Live Vaccine, Industry Ranking, 2023 VS 2024

2.4 Global Coccidia Virus Live Vaccine Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Coccidia Virus Live Vaccine Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Coccidia Virus Live Vaccine, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Coccidia Virus Live Vaccine, Product Offered and Application

2.8 Global Key Manufacturers of Coccidia Virus Live Vaccine, Date of Enter into This Industry

2.9 Coccidia Virus Live Vaccine Market Competitive Situation and Trends

2.9.1 Coccidia Virus Live Vaccine Market Concentration Rate

2.9.2 Global 5 and 10 Largest Coccidia Virus Live Vaccine Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Coccidia Virus Live Vaccine Production by Region

3.1 Global Coccidia Virus Live Vaccine Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Coccidia Virus Live Vaccine Production Value by Region (2020-2031)

3.2.1 Global Coccidia Virus Live Vaccine Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Coccidia Virus Live Vaccine by Region (2026-2031)

3.3 Global Coccidia Virus Live Vaccine Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Coccidia Virus Live Vaccine Production Volume by Region (2020-2031)

3.4.1 Global Coccidia Virus Live Vaccine Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Coccidia Virus Live Vaccine by Region (2026-2031)

3.5 Global Coccidia Virus Live Vaccine Market Price Analysis by Region (2020-2025)

3.6 Global Coccidia Virus Live Vaccine Production and Value, Year-over-Year Growth

3.6.1 North America Coccidia Virus Live Vaccine Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Coccidia Virus Live Vaccine Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Coccidia Virus Live Vaccine Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Coccidia Virus Live Vaccine Production Value Estimates and Forecasts (2020-2031)

4 Coccidia Virus Live Vaccine Consumption by Region

4.1 Global Coccidia Virus Live Vaccine Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Coccidia Virus Live Vaccine Consumption by Region (2020-2031)

4.2.1 Global Coccidia Virus Live Vaccine Consumption by Region (2020-2025)

4.2.2 Global Coccidia Virus Live Vaccine Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Coccidia Virus Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Coccidia Virus Live Vaccine Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Coccidia Virus Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Coccidia Virus Live Vaccine Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Coccidia Virus Live Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Coccidia Virus Live Vaccine Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Coccidia Virus Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Coccidia Virus Live Vaccine Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Coccidia Virus Live Vaccine Production by Type (2020-2031)

5.1.1 Global Coccidia Virus Live Vaccine Production by Type (2020-2025)

5.1.2 Global Coccidia Virus Live Vaccine Production by Type (2026-2031)

5.1.3 Global Coccidia Virus Live Vaccine Production Market Share by Type (2020-2031)

5.2 Global Coccidia Virus Live Vaccine Production Value by Type (2020-2031)

5.2.1 Global Coccidia Virus Live Vaccine Production Value by Type (2020-2025)

5.2.2 Global Coccidia Virus Live Vaccine Production Value by Type (2026-2031)

5.2.3 Global Coccidia Virus Live Vaccine Production Value Market Share by Type (2020-2031)

5.3 Global Coccidia Virus Live Vaccine Price by Type (2020-2031)

6 Segment by Application

6.1 Global Coccidia Virus Live Vaccine Production by Application (2020-2031)

6.1.1 Global Coccidia Virus Live Vaccine Production by Application (2020-2025)

6.1.2 Global Coccidia Virus Live Vaccine Production by Application (2026-2031)

6.1.3 Global Coccidia Virus Live Vaccine Production Market Share by Application (2020-2031)

6.2 Global Coccidia Virus Live Vaccine Production Value by Application (2020-2031)

6.2.1 Global Coccidia Virus Live Vaccine Production Value by Application (2020-2025)

6.2.2 Global Coccidia Virus Live Vaccine Production Value by Application (2026-2031)

6.2.3 Global Coccidia Virus Live Vaccine Production Value Market Share by Application (2020-2031)

6.3 Global Coccidia Virus Live Vaccine Price by Application (2020-2031)

7 Key Companies Profiled

7.1 MSD Animal Health

7.1.1 MSD Animal Health Coccidia Virus Live Vaccine Company Information

7.1.2 MSD Animal Health Coccidia Virus Live Vaccine Product Portfolio

7.1.3 MSD Animal Health Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.1.4 MSD Animal Health Main Business and Markets Served

7.1.5 MSD Animal Health Recent Developments/Updates

7.2 Boehringer Ingelheim

7.2.1 Boehringer Ingelheim Coccidia Virus Live Vaccine Company Information

7.2.2 Boehringer Ingelheim Coccidia Virus Live Vaccine Product Portfolio

7.2.3 Boehringer Ingelheim Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Boehringer Ingelheim Main Business and Markets Served

7.2.5 Boehringer Ingelheim Recent Developments/Updates

7.3 HIPRA

7.3.1 HIPRA Coccidia Virus Live Vaccine Company Information

7.3.2 HIPRA Coccidia Virus Live Vaccine Product Portfolio

7.3.3 HIPRA Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.3.4 HIPRA Main Business and Markets Served

7.3.5 HIPRA Recent Developments/Updates

7.4 Bioproperties

7.4.1 Bioproperties Coccidia Virus Live Vaccine Company Information

7.4.2 Bioproperties Coccidia Virus Live Vaccine Product Portfolio

7.4.3 Bioproperties Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Bioproperties Main Business and Markets Served

7.4.5 Bioproperties Recent Developments/Updates

7.5 Huvepharma

7.5.1 Huvepharma Coccidia Virus Live Vaccine Company Information

7.5.2 Huvepharma Coccidia Virus Live Vaccine Product Portfolio

7.5.3 Huvepharma Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Huvepharma Main Business and Markets Served

7.5.5 Huvepharma Recent Developments/Updates

7.6 Nisseiken

7.6.1 Nisseiken Coccidia Virus Live Vaccine Company Information

7.6.2 Nisseiken Coccidia Virus Live Vaccine Product Portfolio

7.6.3 Nisseiken Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Nisseiken Main Business and Markets Served

7.6.5 Nisseiken Recent Developments/Updates

7.7 Biopharm

7.7.1 Biopharm Coccidia Virus Live Vaccine Company Information

7.7.2 Biopharm Coccidia Virus Live Vaccine Product Portfolio

7.7.3 Biopharm Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Biopharm Main Business and Markets Served

7.7.5 Biopharm Recent Developments/Updates

7.8 Ceva Santé Animale

7.8.1 Ceva Santé Animale Coccidia Virus Live Vaccine Company Information

7.8.2 Ceva Santé Animale Coccidia Virus Live Vaccine Product Portfolio

7.8.3 Ceva Santé Animale Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Ceva Santé Animale Main Business and Markets Served

7.8.5 Ceva Santé Animale Recent Developments/Updates

7.9 Vaxxinova

7.9.1 Vaxxinova Coccidia Virus Live Vaccine Company Information

7.9.2 Vaxxinova Coccidia Virus Live Vaccine Product Portfolio

7.9.3 Vaxxinova Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Vaxxinova Main Business and Markets Served

7.9.5 Vaxxinova Recent Developments/Updates

7.10 Foshan Standard Biotech

7.10.1 Foshan Standard Biotech Coccidia Virus Live Vaccine Company Information

7.10.2 Foshan Standard Biotech Coccidia Virus Live Vaccine Product Portfolio

7.10.3 Foshan Standard Biotech Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Foshan Standard Biotech Main Business and Markets Served

7.10.5 Foshan Standard Biotech Recent Developments/Updates

7.11 Qilu Qingda Bio-Pharmaceutical

7.11.1 Qilu Qingda Bio-Pharmaceutical Coccidia Virus Live Vaccine Company Information

7.11.2 Qilu Qingda Bio-Pharmaceutical Coccidia Virus Live Vaccine Product Portfolio

7.11.3 Qilu Qingda Bio-Pharmaceutical Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Qilu Qingda Bio-Pharmaceutical Main Business and Markets Served

7.11.5 Qilu Qingda Bio-Pharmaceutical Recent Developments/Updates

7.12 Skystar Bio-pharm

7.12.1 Skystar Bio-pharm Coccidia Virus Live Vaccine Company Information

7.12.2 Skystar Bio-pharm Coccidia Virus Live Vaccine Product Portfolio

7.12.3 Skystar Bio-pharm Coccidia Virus Live Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Skystar Bio-pharm Main Business and Markets Served

7.12.5 Skystar Bio-pharm Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Coccidia Virus Live Vaccine Industry Chain Analysis

8.2 Coccidia Virus Live Vaccine Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Coccidia Virus Live Vaccine Production Mode & Process Analysis

8.4 Coccidia Virus Live Vaccine Sales and Marketing

8.4.1 Coccidia Virus Live Vaccine Sales Channels

8.4.2 Coccidia Virus Live Vaccine Distributors

8.5 Coccidia Virus Live Vaccine Customer Analysis

9 Coccidia Virus Live Vaccine Market Dynamics

9.1 Coccidia Virus Live Vaccine Industry Trends

9.2 Coccidia Virus Live Vaccine Market Drivers

9.3 Coccidia Virus Live Vaccine Market Challenges

9.4 Coccidia Virus Live Vaccine Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

MSD Animal Health

Boehringer Ingelheim

Hipra

Bioproperties Pty Ltd

Foshan Standard Biotech

Qilu Qingda Bio-Pharmaceutical

Skystar Bio-Pharm

List of Tables

Table 1. Global Coccidia Virus Live Vaccine Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Coccidia Virus Live Vaccine Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Coccidia Virus Live Vaccine Production Capacity (K Units) by Manufacturers in 2024

Table 4. Global Coccidia Virus Live Vaccine Production by Manufacturers (2020-2025) & (K Units)

Table 5. Global Coccidia Virus Live Vaccine Production Market Share by Manufacturers (2020-2025)

Table 6. Global Coccidia Virus Live Vaccine Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Coccidia Virus Live Vaccine Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Coccidia Virus Live Vaccine, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Coccidia Virus Live Vaccine as of 2024)

Table 10. Global Market Coccidia Virus Live Vaccine Average Price by Manufacturers (US$/Unit) & (2020-2025)

Table 11. Global Key Manufacturers of Coccidia Virus Live Vaccine, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Coccidia Virus Live Vaccine, Product Offered and Application

Table 13. Global Key Manufacturers of Coccidia Virus Live Vaccine, Date of Enter into This Industry

Table 14. Global Coccidia Virus Live Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Coccidia Virus Live Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Coccidia Virus Live Vaccine Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Coccidia Virus Live Vaccine Production Value Market Share by Region (2020-2025)

Table 19. Global Coccidia Virus Live Vaccine Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Coccidia Virus Live Vaccine Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Coccidia Virus Live Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Coccidia Virus Live Vaccine Production (K Units) by Region (2020-2025)

Table 23. Global Coccidia Virus Live Vaccine Production Market Share by Region (2020-2025)

Table 24. Global Coccidia Virus Live Vaccine Production (K Units) Forecast by Region (2026-2031)

Table 25. Global Coccidia Virus Live Vaccine Production Market Share Forecast by Region (2026-2031)

Table 26. Global Coccidia Virus Live Vaccine Market Average Price (US$/Unit) by Region (2020-2025)

Table 27. Global Coccidia Virus Live Vaccine Market Average Price (US$/Unit) by Region (2026-2031)

Table 28. Global Coccidia Virus Live Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)

Table 29. Global Coccidia Virus Live Vaccine Consumption by Region (2020-2025) & (K Units)

Table 30. Global Coccidia Virus Live Vaccine Consumption Market Share by Region (2020-2025)

Table 31. Global Coccidia Virus Live Vaccine Forecasted Consumption by Region (2026-2031) & (K Units)

Table 32. Global Coccidia Virus Live Vaccine Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Coccidia Virus Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 34. North America Coccidia Virus Live Vaccine Consumption by Country (2020-2025) & (K Units)

Table 35. North America Coccidia Virus Live Vaccine Consumption by Country (2026-2031) & (K Units)

Table 36. Europe Coccidia Virus Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 37. Europe Coccidia Virus Live Vaccine Consumption by Country (2020-2025) & (K Units)

Table 38. Europe Coccidia Virus Live Vaccine Consumption by Country (2026-2031) & (K Units)

Table 39. Asia Pacific Coccidia Virus Live Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)

Table 40. Asia Pacific Coccidia Virus Live Vaccine Consumption by Region (2020-2025) & (K Units)

Table 41. Asia Pacific Coccidia Virus Live Vaccine Consumption by Region (2026-2031) & (K Units)

Table 42. Latin America, Middle East & Africa Coccidia Virus Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 43. Latin America, Middle East & Africa Coccidia Virus Live Vaccine Consumption by Country (2020-2025) & (K Units)

Table 44. Latin America, Middle East & Africa Coccidia Virus Live Vaccine Consumption by Country (2026-2031) & (K Units)

Table 45. Global Coccidia Virus Live Vaccine Production (K Units) by Type (2020-2025)

Table 46. Global Coccidia Virus Live Vaccine Production (K Units) by Type (2026-2031)

Table 47. Global Coccidia Virus Live Vaccine Production Market Share by Type (2020-2025)

Table 48. Global Coccidia Virus Live Vaccine Production Market Share by Type (2026-2031)

Table 49. Global Coccidia Virus Live Vaccine Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Coccidia Virus Live Vaccine Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Coccidia Virus Live Vaccine Production Value Market Share by Type (2020-2025)

Table 52. Global Coccidia Virus Live Vaccine Production Value Market Share by Type (2026-2031)

Table 53. Global Coccidia Virus Live Vaccine Price (US$/Unit) by Type (2020-2025)

Table 54. Global Coccidia Virus Live Vaccine Price (US$/Unit) by Type (2026-2031)

Table 55. Global Coccidia Virus Live Vaccine Production (K Units) by Application (2020-2025)

Table 56. Global Coccidia Virus Live Vaccine Production (K Units) by Application (2026-2031)

Table 57. Global Coccidia Virus Live Vaccine Production Market Share by Application (2020-2025)

Table 58. Global Coccidia Virus Live Vaccine Production Market Share by Application (2026-2031)

Table 59. Global Coccidia Virus Live Vaccine Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Coccidia Virus Live Vaccine Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Coccidia Virus Live Vaccine Production Value Market Share by Application (2020-2025)

Table 62. Global Coccidia Virus Live Vaccine Production Value Market Share by Application (2026-2031)

Table 63. Global Coccidia Virus Live Vaccine Price (US$/Unit) by Application (2020-2025)

Table 64. Global Coccidia Virus Live Vaccine Price (US$/Unit) by Application (2026-2031)

Table 65. MSD Animal Health Coccidia Virus Live Vaccine Company Information

Table 66. MSD Animal Health Coccidia Virus Live Vaccine Specification and Application

Table 67. MSD Animal Health Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 68. MSD Animal Health Main Business and Markets Served

Table 69. MSD Animal Health Recent Developments/Updates

Table 70. Boehringer Ingelheim Coccidia Virus Live Vaccine Company Information

Table 71. Boehringer Ingelheim Coccidia Virus Live Vaccine Specification and Application

Table 72. Boehringer Ingelheim Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Boehringer Ingelheim Main Business and Markets Served

Table 74. Boehringer Ingelheim Recent Developments/Updates

Table 75. HIPRA Coccidia Virus Live Vaccine Company Information

Table 76. HIPRA Coccidia Virus Live Vaccine Specification and Application

Table 77. HIPRA Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. HIPRA Main Business and Markets Served

Table 79. HIPRA Recent Developments/Updates

Table 80. Bioproperties Coccidia Virus Live Vaccine Company Information

Table 81. Bioproperties Coccidia Virus Live Vaccine Specification and Application

Table 82. Bioproperties Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Bioproperties Main Business and Markets Served

Table 84. Bioproperties Recent Developments/Updates

Table 85. Huvepharma Coccidia Virus Live Vaccine Company Information

Table 86. Huvepharma Coccidia Virus Live Vaccine Specification and Application

Table 87. Huvepharma Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Huvepharma Main Business and Markets Served

Table 89. Huvepharma Recent Developments/Updates

Table 90. Nisseiken Coccidia Virus Live Vaccine Company Information

Table 91. Nisseiken Coccidia Virus Live Vaccine Specification and Application

Table 92. Nisseiken Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Nisseiken Main Business and Markets Served

Table 94. Nisseiken Recent Developments/Updates

Table 95. Biopharm Coccidia Virus Live Vaccine Company Information

Table 96. Biopharm Coccidia Virus Live Vaccine Specification and Application

Table 97. Biopharm Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Biopharm Main Business and Markets Served

Table 99. Biopharm Recent Developments/Updates

Table 100. Ceva Santé Animale Coccidia Virus Live Vaccine Company Information

Table 101. Ceva Santé Animale Coccidia Virus Live Vaccine Specification and Application

Table 102. Ceva Santé Animale Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Ceva Santé Animale Main Business and Markets Served

Table 104. Ceva Santé Animale Recent Developments/Updates

Table 105. Vaxxinova Coccidia Virus Live Vaccine Company Information

Table 106. Vaxxinova Coccidia Virus Live Vaccine Specification and Application

Table 107. Vaxxinova Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Vaxxinova Main Business and Markets Served

Table 109. Vaxxinova Recent Developments/Updates

Table 110. Foshan Standard Biotech Coccidia Virus Live Vaccine Company Information

Table 111. Foshan Standard Biotech Coccidia Virus Live Vaccine Specification and Application

Table 112. Foshan Standard Biotech Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Foshan Standard Biotech Main Business and Markets Served

Table 114. Foshan Standard Biotech Recent Developments/Updates

Table 115. Qilu Qingda Bio-Pharmaceutical Coccidia Virus Live Vaccine Company Information

Table 116. Qilu Qingda Bio-Pharmaceutical Coccidia Virus Live Vaccine Specification and Application

Table 117. Qilu Qingda Bio-Pharmaceutical Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Qilu Qingda Bio-Pharmaceutical Main Business and Markets Served

Table 119. Qilu Qingda Bio-Pharmaceutical Recent Developments/Updates

Table 120. Skystar Bio-pharm Coccidia Virus Live Vaccine Company Information

Table 121. Skystar Bio-pharm Coccidia Virus Live Vaccine Specification and Application

Table 122. Skystar Bio-pharm Coccidia Virus Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Skystar Bio-pharm Main Business and Markets Served

Table 124. Skystar Bio-pharm Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Coccidia Virus Live Vaccine Distributors List

Table 128. Coccidia Virus Live Vaccine Customers List

Table 129. Coccidia Virus Live Vaccine Market Trends

Table 130. Coccidia Virus Live Vaccine Market Drivers

Table 131. Coccidia Virus Live Vaccine Market Challenges

Table 132. Coccidia Virus Live Vaccine Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Coccidia Virus Live Vaccine

Figure 2. Global Coccidia Virus Live Vaccine Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Coccidia Virus Live Vaccine Market Share by Type: 2024 VS 2031

Figure 4. Bivalent Vaccine Product Picture

Figure 5. Trivalent Vaccine Product Picture

Figure 6. Quadrivalent Vaccine Product Picture

Figure 7. Global Coccidia Virus Live Vaccine Market Value by Application, (US$ Million) & (2020-2031)

Figure 8. Global Coccidia Virus Live Vaccine Market Share by Application: 2024 VS 2031

Figure 9. Poultry

Figure 10. Rabbit

Figure 11. Other

Figure 12. Global Coccidia Virus Live Vaccine Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Coccidia Virus Live Vaccine Production Value (US$ Million) & (2020-2031)

Figure 14. Global Coccidia Virus Live Vaccine Production Capacity (K Units) & (2020-2031)

Figure 15. Global Coccidia Virus Live Vaccine Production (K Units) & (2020-2031)

Figure 16. Global Coccidia Virus Live Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 17. Coccidia Virus Live Vaccine Report Years Considered

Figure 18. Coccidia Virus Live Vaccine Production Share by Manufacturers in 2024

Figure 19. Global Coccidia Virus Live Vaccine Production Value Share by Manufacturers (2024)

Figure 20. Coccidia Virus Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. The Global 5 and 10 Largest Players: Market Share by Coccidia Virus Live Vaccine Revenue in 2024

Figure 22. Global Coccidia Virus Live Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 23. Global Coccidia Virus Live Vaccine Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 24. Global Coccidia Virus Live Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 25. Global Coccidia Virus Live Vaccine Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 26. North America Coccidia Virus Live Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. Europe Coccidia Virus Live Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. China Coccidia Virus Live Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Japan Coccidia Virus Live Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 30. Global Coccidia Virus Live Vaccine Consumption by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 31. Global Coccidia Virus Live Vaccine Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 32. North America Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 33. North America Coccidia Virus Live Vaccine Consumption Market Share by Country (2020-2031)

Figure 34. U.S. Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 35. Canada Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 36. Europe Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 37. Europe Coccidia Virus Live Vaccine Consumption Market Share by Country (2020-2031)

Figure 38. Germany Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 39. France Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 40. U.K. Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 41. Italy Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 42. Russia Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 43. Asia Pacific Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 44. Asia Pacific Coccidia Virus Live Vaccine Consumption Market Share by Region (2020-2031)

Figure 45. China Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 46. Japan Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 47. South Korea Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 48. China Taiwan Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 49. Southeast Asia Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 50. India Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 51. Latin America, Middle East & Africa Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 52. Latin America, Middle East & Africa Coccidia Virus Live Vaccine Consumption Market Share by Country (2020-2031)

Figure 53. Mexico Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 54. Brazil Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 55. Turkey Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 56. GCC Countries Coccidia Virus Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 57. Global Production Market Share of Coccidia Virus Live Vaccine by Type (2020-2031)

Figure 58. Global Production Value Market Share of Coccidia Virus Live Vaccine by Type (2020-2031)

Figure 59. Global Coccidia Virus Live Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 60. Global Production Market Share of Coccidia Virus Live Vaccine by Application (2020-2031)

Figure 61. Global Production Value Market Share of Coccidia Virus Live Vaccine by Application (2020-2031)

Figure 62. Global Coccidia Virus Live Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 63. Coccidia Virus Live Vaccine Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions